Literature DB >> 12975411

Increased distance between mitral valve coaptation point and mitral annular plane: significance and correlations in patients with heart failure.

S E Karagiannis1, G T Karatasakis, N Koutsogiannis, G D Athanasopoulos, D V Cokkinos.   

Abstract

OBJECTIVE: To measure the distance between the mitral leaflet coaptation point and the mitral annulus (CPMA) and assess the relation of this index to structural and functional characteristics of the failing left ventricle.
DESIGN: Echocardiographic indices and CPMA were measured at baseline and again during dobutamine infusion and leg lifting. Left ventricular diastolic and systolic dimensions, left ventricular ejection fraction (LVEF) by Simpson's rule, mitral annulus dimension, and E point septal separation were correlated with CPMA.
SETTING: Tertiary referral centre. PATIENTS: The total study population of 129 patients included 94 with LVEF < 35% and 35 with LVEF 35%-45%; 76 had coronary artery disease and 53 had dilated cardiomyopathy.
INTERVENTIONS: A dobutamine infusion was given in 18 patients and preload increase by leg lifting in 28. MAIN OUTCOME MEASURES: Correlations between CPMA and contractility indices at baseline and during interventions.
RESULTS: CPMA was correlated with left ventricular diastolic dimension (r = 0.52), left ventricular systolic dimension (r = 0.53), LVEF (r = -0.44), fractional shortening (r = -0.42), E point septal separation (r = 0.48), and mitral annulus dimension (r = 0.44) (all p < 0.001). Dobutamine decreased CPMA from (mean (SD)) 12.04 (3.64) mm to 8.92 (2.56) mm and increased LVEF from 27 (6.2)% at baseline to 33.4 (6.9)% at 10 microg/kg/min (both p < 0.001). These changes were strongly related (r = 0.68, p < 0.007). After leg lifting, CPMA decreased from 13 (4) mm at baseline to 10 (3) mm (p < 0.001), and LVEF increased from 32 (11)% at baseline to 39 (11)% (p < 0.001). Fractional shortening and left ventricular diastolic dimension also increased (p < 0.001) and mitral annulus dimension and E point septal separation decreased (p < 0.002), but left ventricular systolic dimension did not change.
CONCLUSIONS: The mechanism displacing the mitral coaptation point towards the left ventricular apex is multifactorial. The correlations between CPMA difference (before versus after interventions) and ejection fraction difference (before versus after interventions) shows that this index depends mainly on left ventricular function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975411      PMCID: PMC1767909          DOI: 10.1136/heart.89.10.1174

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Prevalence and mechanisms of mitral regurgitation in the absence of intrinsic abnormalities of the mitral leaflets.

Authors:  S Kaul; J D Pearlman; D A Touchstone; L Esquival
Journal:  Am Heart J       Date:  1989-11       Impact factor: 4.749

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

3.  Incomplete mitral leaflet closure in patients with papillary muscle dysfunction.

Authors:  R W Godley; L S Wann; E W Rogers; H Feigenbaum; A E Weyman
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

4.  The Mitral Regurgitation Index: an echocardiographic guide to severity.

Authors:  L Thomas; E Foster; J I Hoffman; N B Schiller
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

Review 5.  [Functional mitral insufficiency: a neglected vascular lesion?].

Authors:  P V Ennezat; D Logeart; J Lachmann; T H LeJemtel; A Cohen-Solal
Journal:  Arch Mal Coeur Vaiss       Date:  2001-11

6.  Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation.

Authors:  Y Otsuji; M D Handschumacher; N Liel-Cohen; H Tanabe; L Jiang; E Schwammenthal; J L Guerrero; L A Nicholls; G J Vlahakes; R A Levine
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

7.  Mechanism of ischemic mitral regurgitation. An experimental evaluation.

Authors:  S Kaul; W D Spotnitz; W P Glasheen; D A Touchstone
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

8.  Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure.

Authors:  T Kono; H N Sabbah; H Rosman; M Alam; S Jafri; S Goldstein
Journal:  J Am Coll Cardiol       Date:  1992-12       Impact factor: 24.094

9.  Cross-sectional echocardiographic spectrum of papillary muscle dysfunction.

Authors:  S Ogawa; F E Hubbard; T J Mardelli; L S Dreifus
Journal:  Am Heart J       Date:  1979-03       Impact factor: 4.749

10.  Value of two-dimensional echocardiographic detection of incomplete mitral leaflet closure.

Authors:  E L Kinney; M J Frangi
Journal:  Am Heart J       Date:  1985-01       Impact factor: 4.749

View more
  4 in total

1.  The extents of mitral leaflet opening and closure are determined by left ventricular systolic function.

Authors:  S Kaul
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 2.  Mitral regurgitation in chronic heart failure: more questions than answers?

Authors:  Mandeep R Mehra; Mihai Gheorghiade; Robert O Bonow
Journal:  Curr Cardiol Rep       Date:  2004-03       Impact factor: 2.931

Review 3.  Surgical treatment of functional mitral regurgitation in dilated cardiomyopathy.

Authors:  Hussein S Al-Amri; Abdulrahman M Al-Moghairi; Rieda M El Oakley
Journal:  J Saudi Heart Assoc       Date:  2011-04-16

4.  Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial.

Authors:  Maryse Palardy; Lynne W Stevenson; Gudaye Tasissa; Michele A Hamilton; Robert C Bourge; Thomas G Disalvo; Uri Elkayam; James A Hill; Sharon C Reimold
Journal:  Circ Heart Fail       Date:  2009-04-14       Impact factor: 8.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.